Fyn stimulates the progression of pancreatic cancer via Fyn-GluN2b-AKT axis.

CONCLUSIONS: We investigated the potential involvement of Fyn in the progression of pancreatic cancer, and therefore indicated Fyn as a possible therapeutic target for pancreatic cancer. PMID: 31957823 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research